期刊文献+

经尿道绿激光汽化联合电切割治疗前列腺增生的应用与创伤评价 被引量:1

Application of photoselective vaporization combined with transurethral resection prostate in the treatment of benign prostatic hyperplasia and the assessment of the degree of trauma
下载PDF
导出
摘要 目的:应用定量指标白细胞介素6和C-反应蛋白评估经尿道绿激光联合电切割手术对机体的创伤程度,进而评价其治疗老年前列腺增生的可行性。方法:选择2005-06/2006-04在解放军第四军医大学西京医院住院的良性前列腺增生患者98例(年龄>60岁),分别行开放性手术(28例)、经尿道绿激光汽化合并电切割术(PVP+TURP组,33例)和经尿道绿激光汽化术(PVP组,37例)。绿激光汽化采用美国Laserscope公司生产的非接触式绿激光治疗系统,额定输出汽化功率为80W,电凝功率为30W。用酶联免症吸附法测定3组患者手术前2h,术后24,48h血清中白细胞介素6和C-反应蛋白水平。结果:98例患者全部进入结果分析。①血清白细胞介素6水平:术前2h3组比较差异不显著(P>0.05),术后24和48h均明显高于术前(P<0.05);术后24,48h开放性手术组高于PVP组和PVP+TURP组[24h:(5.97±1.35),(1.81±1.64),(2.44±1.45)μg/L,P<0.05;48h:(1.63±0.86),(0.77±0.51),(0.80±1.46),P<0.05]。②血清C-反应蛋白水平:术前2h3组比较差异不显著(P>0.05),术后24和48h均明显高于术前(P<0.05);术后24,48h开放性手术组高于PVP组和PVP+TURP组[24h:(62.38±13.65),(10.03±4.05),(28.57±9.8)mg/L,P<0.05;48h:(118.85±20.82),(38.86±8.35),(69.44±13.66),P<0.05];PVP+TURP组高于PVP组(P<0.05)。结论:在这3种术式中,开放性手术对机体的创伤最大,机体急性时相反应最显著,经尿道绿激光汽化术合并电切割术对机体创伤较轻,可用于治疗老年前列腺增生症。 AIM: To investigate the application of photoselective vaporization (PVP) combined with transurethral resection prostate (TURP) and access the traumatic degree of open operation (OP), PVP or photoselective vaporization combined with transurethral resection of the prostate (PVP+TURP). METHODS: Ninety-eight inpatients (who were older than 60 years) with benign prostatic hyperplasia (BPH) were selected from Xijing Hospital Affiliated to Fourth Military Medical University of Chinese PLA between June 2005 and April 2006. Patients underwent surgical treatments; OP (n =28), PVP (n =37) and PVP+TURP (n =33) respectively. The PVP that adopted was non-contact PVP system designed by American Laserscope Company, and the vaporized power of nominal out was 80 W and the electric coagulation power was 30 W. The enzyme linked immunosorbent assay (ELISA) was used to detect the levels of interleukin-6 (IL-6) and C reactive protein (CRP) of patients in all groups at two hours before the operation, 24 hours, and 48 hours after he operation respectively. RESULTS : Totally 98 patients were involved in the analysis of results. ① The level of serum IL-6: There was no significant difference among the three groups at two hours before the operation (P 〈 0.05), while it was significantly higher at 24 hours and 48 hours after the operation than that before the surgery (P 〈 0.05). Moreover, it was higher in the OP group than that in the PVP group and PVP+TURP group at 24 and 48 hours after the operation [24^th hour: (5.97±1.35), ( 1.81 ±1.64 ), (2.44±1.45) ug/L, P 〈 0.05; 48^th hour: ( 1.63±0.86), (0.77±0.51), (0.80±1.46), P 〈 0.05]. Level of serum CRP: No significant difference was found among the three groups at 2 hours before the operation (P 〉 0.05), while it was significantly higher at 24 and 48 hours after the operation than that before the surgery (P 〈 0.05), and it was higher in the OP group at 24 and 48 hours after the surgery than that in the PVP group and PVP+TURP group [24^th hour: (62.38±13.65), (10.03±4.05), (28.57±9.8) mg/L,P 〈 0.05;48= hour: (118.85±20.82), (38.86±8.35), (69.44±13.66) ,P 〈 0.05]. Besides, it was higher in the PVP+TURP group than that in the PVP group (P 〈 0.05). CONCLUSION: Extent of tissue damage and the degree of acute phase reaction by OP are the severest and the least by PVP, which can be adopted in the treatment of BPH in eldedy patients.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2007年第1期107-110,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献22

  • 1Bachmann A,Schurch L,Ruszat R,et al.Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP):a prospective bi-centre study of perioperative morbidity and early functional outcome.Eur Urol 2005;48(6):965-971
  • 2Te AE.The development of laser prostatectomy.BJU Iht 2004; 93:262-265
  • 3Kuntz RM.Current role of lasers in the treatment of benign prostatic hyperplasia(BPH).Eur Urol 2006;49(6):961-969
  • 4Te AE,Malloy TR,Stein BS,et al.Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia:12-month results from the first United States multicenter prospective trial.J Urol 2004;172(4 Pt 1):1404-1408
  • 5Malek RS,Nahen K.Photoselective vaporization of the prostate (PVP):KTP laser therapy of obstructive benign prostatic hyperplasia.AUA-Update 2004;23:153-160
  • 6Malek RS,Kuntzman RS,Barrett DM.High power potassiumtitanyl-phosphate laser vaporization prostatectomy.J Urol 2000;163(6):1730-1733
  • 7Kuntzman RS,Malek RS,Barrett DM,et al.High power (60 watt)potassium titanyl phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers.Urology 1997;49:703-708
  • 8Kuntzman RS,Malek RS,Barrett DM,et al.Potassium-titanylphosphate laser vaporization of the prostate:a comparative functional and pathologic study in canines.Urology 1996;48(4):575-583
  • 9张波,王禾,钟林.隧道式经尿道前列腺电切术与插入式半导体激光前列腺组织内凝固术联合治疗良性前列腺增生症的创伤评价[J].中国激光医学杂志,2003,12(1):27-30. 被引量:1
  • 10Malek RS,Barrett DM,Kuntzman RS.High2power potassium titanyl2phosphate (KTP/532) laser vaporization prostatectomy:24hours later.Urology 1998;51:254-256

二级参考文献12

  • 1洪宝发,蔡伟,符伟军,杨勇,王威,陈耀富,展洁,张翠娥,李炎唐,崔胜堂.选择性绿激光汽化术治疗良性前列腺增生的临床研究[J].中华泌尿外科杂志,2005,26(1):17-19. 被引量:90
  • 2Uchida T,Ohori M,Soh S,et al.Factors influencing morbidity in patients undergoing transurethral resection of the prostate.Urology,1999 ,53:98-105.
  • 3Anson K.Could the latest generation potassium titanyl phosphate lasers be the ones to make transurethral resection of the prostate an operation of historical interest only? Curr Opin Urol,2004,14:27-29.
  • 4Shingleton WB,Terrell F,Renfroe L,et al.Low-power vs high-power KTP laser:improved method of laser ablation of prostate.J Endourol,1999,13:49-52.
  • 5Hai MA,Malek RS.Photoselective vaporization of the prostate :initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia.J Endourol,2003 ,17 :93-96.
  • 6Reich O,Bachmann A,Schneede P,et al.Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate.J Urol,2004,171 (6 Pt1) :2502-2504.
  • 7Malek RS,Kuntzman RS,Barrett DM.High power potassium-titanyl-phosphate laser vaporization prostatectomy.J Urol,2000,163:1730-1733.
  • 8Te AE,Malloy TR,Stein BS,et al.Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia:12-month results from the first United States multicenter prospective trial.J Urol,2004,172(4 Pt 1) :1404-1408.
  • 9Larson TR.Current treatment options for benign prostatic hyperplasia and their impact on sexual function.Urology ,2003,61:692-698.
  • 10Wada S,Yoshimura R,Kyo M,et al.Comparative study of tran.surethral laser prostatectomy versus transurethral electroresection for benign prostatic hyperplasia.Int J Urol,2000 ,7 :373-377.

共引文献127

同被引文献12

  • 1杨庞,熊剑华.高功率绿激光汽化治疗良性前列腺增生症(附50例报告)[J].中国内镜杂志,2008,14(7):682-684. 被引量:12
  • 2雒向宁,王禾,杨波,刘贺亮,李欣,秦荣良,袁建林,翟振波,马建军.绿激光前列腺汽化术对患者血管内皮功能影响及其围手术期安全性评价[J].第四军医大学学报,2007,28(6):560-562. 被引量:2
  • 3RASSWEILER J, TEBER D, KUNTZ R, et al. Complications of transurethral resection of the prostate (TURP)-incidence, manage-ment, and prevention[J]. Eur Urol, 2006, 50: 969-980.
  • 4REICH O, BACHMANN A, SCHNEEDE P, el al. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate [J]. J Urol, 2004, 171: 2502-2504.
  • 5BACHMANN A, SCHURCH L, RUSZAT R, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperativemorbidity and early functional outcome[J]. Eur Urol, 2005, 48: 965-972.
  • 6BACHMANN A, RUSZAT R, WYLER S, et al. Photoselective vaporization of the prostate: the Basel experience after 108 pro- cedures[J]. Eur Urol, 2005, 47: 798-804.
  • 7MALEK RS, KUNTZMAN RS, BARRETV DM. Photoselective- potassium-titanyl-phosphate laser vaporization of thebenign ob- structive prostate: observations on long-term outcomes [J]. J Urol, 2005, 174: 1344-1348.
  • 8REICH O, BACHMANN A, SIEBELS M, et al. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients[J]. J Urol, 2005, 173: 158-160.
  • 9DOTAN ZA, MOR Y, LEIBOVITCH I, et al. The eficacy and safety of perioperative low molecular weight heparin substitu-tion in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction [J]. J Urol, 2002, 168: 610-613.
  • 10DAVID M, SCOTY VAN, PATRICK of photoselectivevaporization of the greenlight laser versus transurethral one year follow-up[J]. 2008, 179(4): J, et al. A randomised trial prostate (PVP) using the prostatectomy (TURP) with 630-635.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部